Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • Saudi Medical Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Neurosciences Journal
  • Other Publications
    • Saudi Medical Journal
  • My alerts
  • Log in
Neurosciences Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
Research ArticleOriginal Article
Open Access

Prevalence of antidepressant-induced sexual dysfunction among psychiatric outpatients attending a tertiary care hospital

Mohammed AlBreiki, Mandher AlMaqbali, Khalid AlRisi, Hamed AlSinawi, Maryam Al Balushi and Wedad Al Zakwani
Neurosciences Journal January 2020, 25 (1) 55-60; DOI: https://doi.org/10.17712/nsj.2020.1.20190058
Mohammed AlBreiki
From Psychiatry Residency Training Program (AlBreiki, AlRisi), Oman Medical Specialty Board, and from the Department of Behavioral Medicine (AlSinawi, Al Zakwani), College of Medicine and Health Sciences, Sultan Qaboos University, and from Ministry of Health (Al Balushi), Muscat Governorate, Muscat, and from Department of Psychiatry (AlMaqbali), Sohar Hospital, Sohar, Oman.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mandher AlMaqbali
From Psychiatry Residency Training Program (AlBreiki, AlRisi), Oman Medical Specialty Board, and from the Department of Behavioral Medicine (AlSinawi, Al Zakwani), College of Medicine and Health Sciences, Sultan Qaboos University, and from Ministry of Health (Al Balushi), Muscat Governorate, Muscat, and from Department of Psychiatry (AlMaqbali), Sohar Hospital, Sohar, Oman.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Khalid AlRisi
From Psychiatry Residency Training Program (AlBreiki, AlRisi), Oman Medical Specialty Board, and from the Department of Behavioral Medicine (AlSinawi, Al Zakwani), College of Medicine and Health Sciences, Sultan Qaboos University, and from Ministry of Health (Al Balushi), Muscat Governorate, Muscat, and from Department of Psychiatry (AlMaqbali), Sohar Hospital, Sohar, Oman.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hamed AlSinawi
From Psychiatry Residency Training Program (AlBreiki, AlRisi), Oman Medical Specialty Board, and from the Department of Behavioral Medicine (AlSinawi, Al Zakwani), College of Medicine and Health Sciences, Sultan Qaboos University, and from Ministry of Health (Al Balushi), Muscat Governorate, Muscat, and from Department of Psychiatry (AlMaqbali), Sohar Hospital, Sohar, Oman.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maryam Al Balushi
From Psychiatry Residency Training Program (AlBreiki, AlRisi), Oman Medical Specialty Board, and from the Department of Behavioral Medicine (AlSinawi, Al Zakwani), College of Medicine and Health Sciences, Sultan Qaboos University, and from Ministry of Health (Al Balushi), Muscat Governorate, Muscat, and from Department of Psychiatry (AlMaqbali), Sohar Hospital, Sohar, Oman.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wedad Al Zakwani
From Psychiatry Residency Training Program (AlBreiki, AlRisi), Oman Medical Specialty Board, and from the Department of Behavioral Medicine (AlSinawi, Al Zakwani), College of Medicine and Health Sciences, Sultan Qaboos University, and from Ministry of Health (Al Balushi), Muscat Governorate, Muscat, and from Department of Psychiatry (AlMaqbali), Sohar Hospital, Sohar, Oman.
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

References

  1. ↵
    1. Silva MT,
    2. Galvao TF,
    3. Martins SS,
    4. Pereira MG,
    5. Silva MT,
    6. Galvao TF,
    7. et al.
    (2014) Prevalence of depression morbidity among Brazilian adults: a systematic review and meta-analysis. Braz J Psychiatry 36, 262–270.
  2. ↵
    1. Lancet T
    (2018) GBD 2017: a fragile world. The Lancet 392, 1683.
  3. ↵
    1. Angst F,
    2. Stassen HH,
    3. Clayton PJ,
    4. Angst J
    (2002) Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord 68, 167–181.
  4. ↵
    1. Ferguson JM
    (2001) The effects of antidepressants on sexual functioning in depressed patients: A review. J Clin Psychiatry 62, 22–34.
  5. ↵
    1. Montgomery SA,
    2. Baldwin DS,
    3. Riley A
    (2002) Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction. J Affect Disord 69, 119–140.
    1. Torre AL,
    2. Giupponi G,
    3. Duffy D,
    4. Conca A
    (2013) Sexual Dysfunction Related to Psychotropic Drugs: A Critical Review - Part I: Antidepressants. Pharmacopsychiatry 46, 191–199.
  6. ↵
    1. Worsham J,
    2. Bishop JR,
    3. Ellingrod VL
    (Jan, 2007) Antidepressant Associated Sexual Dysfunction: A Review. Journal of College of Psychiatric and Neurological Pharmacists.
  7. ↵
    1. Clayton AH,
    2. Montejo AL
    (2006) Major depressive disorder, antidepressants, and sexual dysfunction. J Clin Psychiatry 67, 33–37.
  8. ↵
    1. Chokka PR,
    2. Hankey JR
    (2018) Assessment and management of sexual dysfunction in the context of depression. Ther Adv Psychopharmacol 8, 13–23.
  9. ↵
    1. Sreelakshmy K,
    2. Velayudhan R,
    3. Kuriakose D,
    4. Nair R,
    5. Sreelakshmy K,
    6. Velayudhan R,
    7. et al.
    (2017) Sexual dysfunction in females with depression: a cross-sectional study. Trends Psychiatry Psychother 39, 106–109.
    1. Serretti A,
    2. Chiesa A
    (2009) Treatment-Emergent Sexual Dysfunction Related to Antidepressants: A Meta-Analysis. J Clin Psychopharmacol 29, 259.
  10. ↵
    1. Montejo AL,
    2. Llorca G,
    3. Izquierdo JA,
    4. Rico-Villademoros F
    (2001) Incidence or sexual dysfunction associated with antidepressant agents: A prospective multicenter study of 1022 outpatients. J Clin Psychiatry 62, 10–21.
  11. ↵
    1. Hsu JH,
    2. Shen WW
    (1995) Male Sexual Side Effects Associated with Antidepressants: A Descriptive Clinical Study of 32 Patients. Int J Psychiatry Med 25, 191–201.
  12. ↵
    1. Kennedy SH,
    2. Eisfeld BS,
    3. Dickens SE,
    4. Bacchiochi JR,
    5. Bagby RM
    (2000) Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry 61, 276–281.
  13. ↵
    1. Balon R,
    2. Yeragani VK,
    3. Pohl R,
    4. Ramesh C
    (1993) Sexual dysfunction during antidepressant treatment. J Clin Psychiatry 54, 209–212.
  14. ↵
    1. Montejo-González AL,
    2. Llorca G,
    3. Izquierdo JA,
    4. Ledesma A,
    5. Bousoño M,
    6. Calcedo A,
    7. et al.
    (1997) SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther 23, 176–194.
  15. ↵
    1. Rosenberg KP,
    2. Bleiberg KL,
    3. Koscis J,
    4. Gross C
    (2003) A Survey of Sexual Side Effects Among Severely Mentally Ill Patients Taking Psychotropic Medications: Impact on Compliance. J Sex Marital Ther 29, 289–296.
  16. ↵
    1. Segraves RT
    (1998) Antidepressant-induced sexual dysfunction. J Clin Psychiatry 59, 48–54.
  17. ↵
    1. Clayton AH,
    2. Pradko JF,
    3. Croft HA,
    4. Montano CB,
    5. Leadbetter RA,
    6. Bolden-Watson C,
    7. et al.
    (2002) Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 63, 357–366.
  18. ↵
    1. Waldinger MD,
    2. Olivier B
    (1998) Selective serotonin reuptake inhibitor-induced sexual dysfunction: clinical and research considerations. Int Clin Psychopharmacol 13, Suppl 6, S27–S33.
  19. ↵
    1. Vanderkooy JD,
    2. Kennedy SH,
    3. Michael RM
    (2002) Antidepressant Side Effects in Depression Patients Treated in a Naturalistic Setting: A Study of Bupropion, Moclobemide, Paroxetine, Sertraline, and Venlafaxine. Can J Psychiatry 47, 174–180.
  20. ↵
    1. Montejo AL,
    2. Llorca G,
    3. Izquierdo JA,
    4. Rico-Villademoros F
    (2001) Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry 62, Suppl 3, 10–21.
  21. ↵
    1. Lee KU,
    2. Lee YM,
    3. Nam JM,
    4. Lee HK,
    5. Kweon YS,
    6. Lee CT,
    7. et al.
    (2010) Antidepressant-Induced Sexual Dysfunction among Newer Antidepressants in a Naturalistic Setting. Psychiatry Investig 7, 55–59.
  22. ↵
    1. Gregorian RS,
    2. Golden KA,
    3. Bahce A,
    4. Goodman C,
    5. Kwong WJ,
    6. Khan ZM
    (2002) Antidepressant-induced sexual dysfunction. Ann Pharmacother 36, 1577–1589.
  23. ↵
    1. Stahl SM
    (2001) The psychopharmacology of sex, Part 1: Neurotransmitters and the 3 phases of the human sexual response. J Clin Psychiatry 62, 80–81.
  24. ↵
    1. Angulo J,
    2. Peiró C,
    3. Sanchez-Ferrer CF,
    4. Gabancho S,
    5. Cuevas P,
    6. Gupta S,
    7. et al.
    (2001) Differential effects of serotonin reuptake inhibitors on erectile responses, NO-production, and neuronal NO synthase expression in rat corpus cavernosum tissue. Br J Pharmacol 134, 1190–1194.
  25. ↵
    1. Goldstein BJ,
    2. Goodnick PJ
    (1998) Selective serotonin reuptake inhibitors in the treatment of affective disorders--III. Tolerability, safety and pharmacoeconomics. J Psychopharmacol 12, S55–S87.
  26. ↵
    1. Chaudhry I,
    2. Neelam K,
    3. Duddu V,
    4. Husain N
    (2008) Ethnicity and psychopharmacology. J Psychopharmacol 22, 673–680.
  27. ↵
    1. Williams VS,
    2. Baldwin DS,
    3. Hogue SL,
    4. Fehnel SE,
    5. Hollis KA,
    6. Edin HM
    (2006) Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey. J Clin Psychiatry 67, 204–210.
PreviousNext
Back to top

In this issue

Neurosciences Journal: 25 (1)
Neurosciences Journal
Vol. 25, Issue 1
1 Jan 2020
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Neurosciences Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prevalence of antidepressant-induced sexual dysfunction among psychiatric outpatients attending a tertiary care hospital
(Your Name) has sent you a message from Neurosciences Journal
(Your Name) thought you would like to see the Neurosciences Journal web site.
Citation Tools
Prevalence of antidepressant-induced sexual dysfunction among psychiatric outpatients attending a tertiary care hospital
Mohammed AlBreiki, Mandher AlMaqbali, Khalid AlRisi, Hamed AlSinawi, Maryam Al Balushi, Wedad Al Zakwani
Neurosciences Journal Jan 2020, 25 (1) 55-60; DOI: 10.17712/nsj.2020.1.20190058

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prevalence of antidepressant-induced sexual dysfunction among psychiatric outpatients attending a tertiary care hospital
Mohammed AlBreiki, Mandher AlMaqbali, Khalid AlRisi, Hamed AlSinawi, Maryam Al Balushi, Wedad Al Zakwani
Neurosciences Journal Jan 2020, 25 (1) 55-60; DOI: 10.17712/nsj.2020.1.20190058
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Ranking the difficulty of the cognitive tasks in Dual-Tasks during walking in healthy adults
  • Exploring physiotherapist’s ability to identify cauda equina syndrome early
  • Does the severity of facet joint osteoarthritis affect facet medial branch radiofrequency thermocoagulation results?
Show more Original Article

Similar Articles

Navigate

  • home

More Information

  • Help

Additional journals

  • All Topics

Other Services

  • About

© 2025 Neurosciences Journal Neurosciences is copyright under the Berne Convention and the International Copyright Convention. All rights reserved. Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3183. Print ISSN 1319-6138.

Powered by HighWire